MedTrace Logo

Post Intravitreal Injection Topical NSAID vs. Patching

NCT03918590 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-04-17

No results posted yet for this study

Summary

A prospective randomized trial, to evaluate post-injection comfort measures comparing topical NSAID (nepafenac 0.3% suspension) and patching.

Conditions

Interventions

DRUG

nepafenac 0.3% suspension (Ilevro; Alcon, Fort Worth, TX)

NSAID

DRUG

Theratears tear drop, (Akron, Ann 111 Arbor, MI)

preservative-free Artificial Tears

OTHER

patching

no drug/ patching

Sponsors & Collaborators

  • The New York Eye & Ear Infirmary

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-03
Primary Completion
2019-05-01
Completion
2019-06-03
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03918590 on ClinicalTrials.gov